Credit: Creative Images/Alamy

Memory T cells ensure that the immune response is more effective against re-infecting pathogens. Two key distinctions between memory CD8+ T cells and their naive counterparts are crucial for this: first, memory T cells have distinct migratory patterns; and second, they survive for longer. New studies by Steinert et al. and Cui et al. offer fresh insight into both of these aspects of memory.

Memory CD8+ T cells have been divided into distinct subsets on the basis of putative trafficking and functional properties. Central memory T (TCM) cells are suggested to be long-lived memory cells that recirculate via secondary lymphoid organs (SLOs), whereas effector memory T (TEM) cells are thought to primarily recirculate between the blood and non-lymphoid tissues and respond rapidly to re-infecting pathogens. A further set of tissue-resident memory T (TRM) cells have been described that are retained in non-lymphoid tissues and do not recirculate. The relative contribution of each subset to immune memory has been unclear; to address this, Steinert et al. developed a quantitative immunofluorescence microscopy (QIM) method. In a mouse model of lymphocytic choriomeningitis virus (LCMV) infection, standard protocols for cell isolation markedly underestimated the frequencies of LCMV-specific memory CD8+ T cells in tissues, particularly in non-lymphoid sites, when compared with QIM. Indeed, QIM analyses suggested that more memory CD8+ T cells are found in the blood and peripheral tissues than in SLOs.

our current paradigms of memory T cell subsets require revision

Parabiosis experiments showed that most memory CD8+ T cells in peripheral tissues do not recirculate. This suggests that the majority of memory CD8+ T cells in non-lymphoid tissues are TRM cells, rather than TEM cells, although bona fide TEM cells could be detected exiting tissues via lymphatics. CD69 expression is often used to define TRM cells, but the authors found that a substantial number of resident memory CD8+ T cells do not express this marker. Furthermore, many of the memory CD8+ T cells that entered peripheral tissues (a migratory behaviour associated with TRM cells or TEM cells) expressed the lymph node-homing molecule CD62L, which is typically used to define TCM cells. In fact, adoptive transfer experiments showed that purified TCM cells and TEM cells were equally efficient at migrating to inflamed peripheral tissues. These data suggest that tissue-resident memory CD8+ T cells markedly outnumber those that are recirculating and that our current paradigms of memory T cell subsets require revision.

Cui et al. explored how metabolic processes regulate longevity in memory CD8+ T cells. They compared gene expression profiles of naive, effector and memory CD8+ T cells and found that the glycerol channel aquaporin 9 (AQP9) was selectively expressed by memory CD8+ T cells. These cells were shown to upregulate AQP9 in response to stimulation with interleukin-7 (IL-7) — and, to a lesser extent, in response to IL-15 — and deficiency of AQP9 impaired the survival of memory but not effector CD8+ T cells during LCMV infection.

Further experiments suggested that AQP9 deficiency impairs memory CD8+ T cell survival by preventing glycerol uptake, which is required for the synthesis of triglycerides. Triglycerides serve as a source of fatty acids for fatty acid oxidation, a metabolic process that generates energy for memory T cell survival. Consistent with this, AQP9-deficient memory CD8+ T cells had reduced ATP levels, and the overexpression of genes involved in triglyceride synthesis prolonged their survival. Additional analyses showed that IL-7 also increases the expression of genes involved in triglyceride synthesis in previously activated but not naive CD8+ T cells. Therefore, IL-7 promotes memory CD8+ T cell survival not only through the induction of anti-apoptotic genes but also by supporting their metabolic activities.